Carmell Free Cash Flow Yield vs Capex To Depreciation Analysis
| CTCXW Stock | 0.06 0 1.96% |
Carmell Therapeutics financial indicator trend analysis is way more than just evaluating Carmell Therapeutics prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Carmell Therapeutics is a good investment. Please check the relationship between Carmell Therapeutics Free Cash Flow Yield and its Capex To Depreciation accounts. Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.
Free Cash Flow Yield vs Capex To Depreciation
Free Cash Flow Yield vs Capex To Depreciation Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Carmell Therapeutics Free Cash Flow Yield account and Capex To Depreciation. At this time, the significance of the direction appears to have pay attention.
The correlation between Carmell Therapeutics' Free Cash Flow Yield and Capex To Depreciation is -1.0. Overlapping area represents the amount of variation of Free Cash Flow Yield that can explain the historical movement of Capex To Depreciation in the same time period over historical financial statements of Carmell Therapeutics, assuming nothing else is changed. The correlation between historical values of Carmell Therapeutics' Free Cash Flow Yield and Capex To Depreciation is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Free Cash Flow Yield of Carmell Therapeutics are associated (or correlated) with its Capex To Depreciation. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Capex To Depreciation has no effect on the direction of Free Cash Flow Yield i.e., Carmell Therapeutics' Free Cash Flow Yield and Capex To Depreciation go up and down completely randomly.
Correlation Coefficient | -1.0 |
| Relationship Direction | Negative |
| Relationship Strength | Strong |
Free Cash Flow Yield
A financial solvency ratio that compares the free cash flow per share a company is expected to earn against its market value per share, calculated as free cash flow per share divided by market price per share.Capex To Depreciation
The ratio of a company's capital expenditures to its depreciation expenses, indicating how much the company is investing in physical assets relative to the aging of existing assets.Most indicators from Carmell Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Carmell Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. Selling General Administrative is likely to drop to about 2.5 M in 2024. Issuance Of Capital Stock is expected to grow at the current pace this year
| 2010 | 2022 | 2023 | 2024 (projected) | Interest Expense | 2.5M | 3.7M | 889.3K | 844.9K | Depreciation And Amortization | 242.1K | 242.6K | 124.8K | 162.5K |
Carmell Therapeutics fundamental ratios Correlations
Click cells to compare fundamentals
Carmell Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Carmell Stock Analysis
When running Carmell Therapeutics' price analysis, check to measure Carmell Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Carmell Therapeutics is operating at the current time. Most of Carmell Therapeutics' value examination focuses on studying past and present price action to predict the probability of Carmell Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Carmell Therapeutics' price. Additionally, you may evaluate how the addition of Carmell Therapeutics to your portfolios can decrease your overall portfolio volatility.